インスリン送達デバイスの世界市場レポート 2025年

インスリン送達デバイス市場規模は、今後数年間で力強い成長が見込まれます。2029年には複合年間成長率（CAGR）8.2％で263億米ドルに成長します。予測期間の成長は、糖尿病人口の増加、糖尿病治療に対する医療費の増加、持続グルコースモニタリングシステムの台頭、自動インスリン送達デバイスの利点に関する患者の意識の高まり、ヘルスケアへの注目の高まりに起因しています。予測期間における主な動向としては、インスリン送達デバイスの技術進歩、デジタル技術とインスリン送達デバイスの統合、人工膵臓システムの開発、インスリン投与技術の進歩、バイオニック技術の進歩などが挙げられます。

糖尿病の有病率の増加は、今後数年間のインスリン送達デバイス市場の成長を促進すると予想されます。糖尿病は、膵臓によるインスリン分泌が不十分であるか、身体がインスリンを効果的に使用できないことによる血糖値の上昇を特徴とする慢性疾患です。糖尿病患者の増加は、座りがちなライフスタイル、食生活の乱れ、世界の肥満率の増加といった要因によるところが大きいです。インスリン送達デバイスは、糖尿病を管理するために不可欠なものです。なぜなら、インスリンをコントロールし、便利な方法で投与することにより、血糖値を効果的にコントロールすることができ、合併症を予防し、全体的な健康を促進することができるからです。例えば、米国の政府機関である疾病対策予防センターによると、2022年12月の時点で、米国における20歳未満の2型糖尿病患者の数は、2060年までに700％近く増加し、22万人に達する可能性があるといいます。さらに、若年層における1型糖尿病の診断は、同期間に65％も増加する可能性があります。このような糖尿病有病率の増加が、インスリン送達装置市場の拡大に拍車をかけています。

インスリン送達デバイス市場の主要企業は、持続的またはカスタマイズ可能なインスリン送達を提供するインスリンポンプなどの革新的な製品の開発に注力しています。インスリンポンプはプログラム可能な医療機器であり、皮下に留置されたカテーテルを介してインスリンを連続的またはオンデマンドで送達します。例えば、2023年5月、米国の医療技術企業であるベータ・バイオニクス社は、iLet ACE PumpとiLet Dosing Decision Softwareについて米国食品医薬品局から承認を受けた。6歳以上の1型糖尿病患者向けに設計されたiLet Bionic Pancreasシステムは、互換性のあるFDA認可の統合持続グルコースモニター（iCGM）と2つのデバイスを統合しています。このシステムは、適応クローズドループアルゴリズムによって駆動される自動インスリン投与（AID）システムを用いて作動し、セットアップに必要なのはユーザーの体重のみで、追加のインスリン投与パラメータは不要です。従来のポンプ療法とは異なり、このシステムでは手動による設定調整が不要であるため、開始と管理が容易です。さらに、iLetデバイスは、食事アナウンス機能を導入し、食事を小、中、大に分類することで、食事時のインスリン投与を簡素化します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界インスリン送達デバイス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のインスリン送達デバイス市場：成長率分析
• 世界のインスリン送達デバイス市場の実績：規模と成長, 2019-2024
• 世界のインスリン送達デバイス市場の予測：規模と成長, 2024-2029, 2034F
• 世界インスリン送達デバイス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のインスリン送達デバイス市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• インスリン注射器
• インスリンジェットインジェクター
• ペンニードル
• 再利用可能なインスリンペン
• 使い捨てインスリンペン
• インスリンポンプ
• 外部ポンプまたはテザーポンプ
• パッチポンプ
• 世界のインスリン送達デバイス市場：疾患適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タイプ1
• タイプ2
• 世界のインスリン送達デバイス市場流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン販売
• 糖尿病クリニックまたはセンター
• 世界のインスリン送達デバイス市場インスリン注射器の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準インスリン注射器
• 固定または調節可能な針の長さを備えたインスリン注射器
• 世界のインスリン送達デバイス市場インスリンジェットインジェクターの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 針なしインスリンジェット注射器
• 高圧インスリンジェットインジェクター
• 世界のインスリン送達デバイス市場ペンニードルの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ショートペンニードル
• ロングペンニードル
• 世界のインスリン送達デバイス市場再利用可能なインスリンペンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 交換可能なカートリッジを備えた再利用可能なペン
• 詰め替え可能なインスリンペン
• 世界のインスリン送達デバイス市場使い捨てインスリンペンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 使い捨てインスリンペン
• 使い捨てプレフィルドインスリンペン
• 世界のインスリン送達デバイス市場インスリンポンプの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 従来のインスリンポンプ
• スマートインスリンポンプ
• 世界のインスリン送達デバイス市場外部ポンプまたはテザーポンプの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 従来の外部インスリンポンプ
• ワイヤレステザーポンプ
• 世界のインスリン送達デバイス市場パッチポンプの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• パッチ型インスリンポンプ
• 統合パッチポンプ

第7章 地域別・国別分析

• 世界のインスリン送達デバイス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のインスリン送達デバイス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• インスリン送達デバイス市場：競合情勢
• インスリン送達デバイス市場：企業プロファイル
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novo Nordisk A/S
• Becton, Dickinson and Company
• EOFlow Co. Ltd.
• Insulet Corporation
• Tandem Diabetes Care Inc.
• Ypsomed Holding AG
• Xeris Pharmaceuticals Inc.
• Beta Bionics Inc.
• Zealand Pharma AS
• Bigfoot Biomedical Inc.
• Emperra GmbH
• Animas Corporation
• Debiotech SA
• CeQur Corporation
• Aerami Therapeutics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• インスリン送達デバイス市場2029：新たな機会を提供する国
• インスリン送達デバイス市場2029：新たな機会を提供するセグメント
• インスリン送達デバイス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Insulin delivery devices are medical tools designed to administer insulin to individuals with diabetes. These devices are essential for managing blood glucose levels in people who are unable to produce sufficient insulin naturally. They help control blood sugar levels effectively, offering flexibility and convenience in insulin administration.

The primary types of insulin delivery devices include insulin syringes, insulin jet injectors, pen needles, reusable insulin pens, disposable insulin pens, insulin pumps, external or tethered pumps, and patch pumps. Insulin syringes, in particular, are designed for the subcutaneous injection of insulin, featuring fine, short needles and clearly marked dosage indicators to ensure precise hormone delivery. These devices are used for both type 1 and type 2 diabetes and are available through various channels, including hospital pharmacies, retail pharmacies, online sales, and diabetes clinics or centers.

The insulin delivery devices market research report is one of a series of new reports from The Business Research Company that provides insulin delivery devices market statistics, including insulin delivery devices industry global market size, regional shares, competitors with a insulin delivery devices market share, detailed insulin delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the insulin delivery devices industry. This insulin delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The insulin delivery devices market size has grown strongly in recent years. It will grow from $17.71 billion in 2024 to $19.22 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to convenience and ease of use offered by insulin delivery devices, favorable reimbursement policies, increasing prevalence of obesity, growing aging population, increasing adoption of insulin pumps.

The insulin delivery devices market size is expected to see strong growth in the next few years. It will grow to $26.3 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to growing prevalence of diabetic population, increasing healthcare expenditure on diabetes care, rise of continuous glucose monitoring systems, growing awareness among patients about benefits of automated insulin delivery devices, rising focus on healthcare. Major trends in the forecast period include technological advancements in insulin delivery devices, integration of digital technology with insulin delivery devices, development of artificial pancreas systems, advancements in insulin administration technology, bionic technology advancements.

The increasing prevalence of diabetes is expected to drive the growth of the insulin delivery device market in the coming years. Diabetes is a chronic condition characterized by elevated blood sugar levels due to either insufficient insulin production by the pancreas or the body's inability to effectively use insulin. The rise in diabetes cases is largely attributed to factors such as sedentary lifestyles, poor diets, and increasing obesity rates worldwide. Insulin delivery devices are essential for managing diabetes, as they allow individuals to control their blood sugar levels effectively by administering insulin in a controlled and convenient manner, thus preventing complications and promoting overall health. For example, according to the Centers for Disease Control and Prevention, a U.S.-based government agency, as of December 2022, the number of young people under 20 with type 2 diabetes in the United States could increase by nearly 700% by 2060, potentially reaching 220,000 individuals. Additionally, diagnoses of type 1 diabetes among young people could rise by as much as 65% over the same period. This growing prevalence of diabetes is fueling the expansion of the insulin delivery device market.

Leading companies in the insulin delivery device market are focusing on developing innovative products, such as insulin pumps, which provide continuous or customizable insulin delivery. Insulin pumps are programmable medical devices that deliver insulin continuously or on demand through a catheter placed under the skin. For instance, in May 2023, Beta Bionics, a U.S.-based medical technology company, received approval from the U.S. Food and Drug Administration for its iLet ACE Pump and iLet Dosing Decision Software. The iLet Bionic Pancreas system, designed for individuals aged six and older with type 1 diabetes, integrates two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). This system operates using an automated insulin dosing (AID) system driven by an adaptive closed-loop algorithm, which only requires the user's body weight for setup and eliminates the need for additional insulin dosing parameters. Unlike traditional pump therapy, this system requires no manual adjustment of settings, making it easier to initiate and manage. Additionally, the iLet device introduces a meal announcement feature that simplifies mealtime insulin dosing by categorizing meals as small, medium, or large, with the algorithm learning and adapting to individual insulin needs over time.

In September 2023, Abbott, a U.S.-based healthcare company, acquired Bigfoot Biomedical for an undisclosed amount. This acquisition strengthens Abbott's position in diabetes care by expanding its renowned FreeStyle Libre portfolio of continuous glucose monitoring technology. The move aligns with Abbott's strategy to advance connected solutions, aiming to personalize and refine diabetes management. Bigfoot Biomedical is a U.S.-based manufacturer of insulin delivery devices.

Major companies operating in the insulin delivery devices market are Sanofi SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic Plc, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, EOFlow Co. Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Xeris Pharmaceuticals Inc., Beta Bionics Inc., Zealand Pharma AS, Bigfoot Biomedical Inc., Emperra GmbH, Animas Corporation, Debiotech SA, CeQur Corporation, Aerami Therapeutics Inc., Alshifa Medical Group, AMF Medical SA, Andain Inc., Avecho Biotechnology Ltd., Apex Medical Devices

North America was the largest region in the insulin delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the insulin delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The insulin delivery devices market consists of sales of insulin infusion sets, insulin reservoirs, insulin pump accessories, and insulin cartridges. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Insulin Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on insulin delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for insulin delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The insulin delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Insulin Syringes; Insulin Jet Injectors; Pen Needles; Reusable Insulin Pens; Disposable Insulin Pens; Insulin Pumps; External Or Tethered Pumps; Patch Pumps
• 2) By Disease Indication: Type 1; Type 2
• 3) By Distribution Channels: Hospital Pharmacies; Retail Pharmacies; Online Sales; Diabetes Clinics Or Centers
• Subsegments:
• 1) By Insulin Syringes: Standard Insulin Syringes; Insulin Syringes With Fixed Or Adjustable Needle Length
• 2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors; High-Pressure Insulin Jet Injectors
• 3) By Pen Needles: Short Pen Needles; Long Pen Needles
• 4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges; Refillable Insulin Pens
• 5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens; Pre-Filled Disposable Insulin Pens
• 6) By Insulin Pumps: Traditional Insulin Pumps; Smart Insulin Pumps
• 7) By External Or Tethered Pumps: Traditional External Insulin Pumps; Wireless Tethered Pumps
• 8) By Patch Pumps: Patch Insulin Pumps; Integrated Patch Pumps
• Companies Mentioned: Sanofi SA; Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Medtronic Plc; Eli Lilly and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Insulin Delivery Devices Market Characteristics

3. Insulin Delivery Devices Market Trends And Strategies

4. Insulin Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Insulin Delivery Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Insulin Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Insulin Delivery Devices Market Growth Rate Analysis
• 5.4. Global Insulin Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Insulin Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Insulin Delivery Devices Total Addressable Market (TAM)

6. Insulin Delivery Devices Market Segmentation

• 6.1. Global Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Insulin Syringes
• Insulin Jet Injectors
• Pen Needles
• Reusable Insulin Pens
• Disposable Insulin Pens
• Insulin Pumps
• External Or Tethered Pumps
• Patch Pumps
• 6.2. Global Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Type 1
• Type 2
• 6.3. Global Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Sales
• Diabetes Clinics Or Centres
• 6.4. Global Insulin Delivery Devices Market, Sub-Segmentation Of Insulin Syringes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Insulin Syringes
• Insulin Syringes With Fixed Or Adjustable Needle Length
• 6.5. Global Insulin Delivery Devices Market, Sub-Segmentation Of Insulin Jet Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Needle-Free Insulin Jet Injectors
• High-Pressure Insulin Jet Injectors
• 6.6. Global Insulin Delivery Devices Market, Sub-Segmentation Of Pen Needles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Short Pen Needles
• Long Pen Needles
• 6.7. Global Insulin Delivery Devices Market, Sub-Segmentation Of Reusable Insulin Pens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reusable Pens With Replaceable Cartridges
• Refillable Insulin Pens
• 6.8. Global Insulin Delivery Devices Market, Sub-Segmentation Of Disposable Insulin Pens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Use Disposable Insulin Pens
• Pre-Filled Disposable Insulin Pens
• 6.9. Global Insulin Delivery Devices Market, Sub-Segmentation Of Insulin Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Traditional Insulin Pumps
• Smart Insulin Pumps
• 6.10. Global Insulin Delivery Devices Market, Sub-Segmentation Of External Or Tethered Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Traditional External Insulin Pumps
• Wireless Tethered Pumps
• 6.11. Global Insulin Delivery Devices Market, Sub-Segmentation Of Patch Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Patch Insulin Pumps
• Integrated Patch Pumps

7. Insulin Delivery Devices Market Regional And Country Analysis

• 7.1. Global Insulin Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Insulin Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Insulin Delivery Devices Market

• 8.1. Asia-Pacific Insulin Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Insulin Delivery Devices Market

• 9.1. China Insulin Delivery Devices Market Overview
• 9.2. China Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Insulin Delivery Devices Market

• 10.1. India Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Insulin Delivery Devices Market

• 11.1. Japan Insulin Delivery Devices Market Overview
• 11.2. Japan Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Insulin Delivery Devices Market

• 12.1. Australia Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Insulin Delivery Devices Market

• 13.1. Indonesia Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Insulin Delivery Devices Market

• 14.1. South Korea Insulin Delivery Devices Market Overview
• 14.2. South Korea Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Insulin Delivery Devices Market

• 15.1. Western Europe Insulin Delivery Devices Market Overview
• 15.2. Western Europe Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Insulin Delivery Devices Market

• 16.1. UK Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Insulin Delivery Devices Market

• 17.1. Germany Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Insulin Delivery Devices Market

• 18.1. France Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Insulin Delivery Devices Market

• 19.1. Italy Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Insulin Delivery Devices Market

• 20.1. Spain Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Insulin Delivery Devices Market

• 21.1. Eastern Europe Insulin Delivery Devices Market Overview
• 21.2. Eastern Europe Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Insulin Delivery Devices Market

• 22.1. Russia Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Insulin Delivery Devices Market

• 23.1. North America Insulin Delivery Devices Market Overview
• 23.2. North America Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Insulin Delivery Devices Market

• 24.1. USA Insulin Delivery Devices Market Overview
• 24.2. USA Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Insulin Delivery Devices Market

• 25.1. Canada Insulin Delivery Devices Market Overview
• 25.2. Canada Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Insulin Delivery Devices Market

• 26.1. South America Insulin Delivery Devices Market Overview
• 26.2. South America Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Insulin Delivery Devices Market

• 27.1. Brazil Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Insulin Delivery Devices Market

• 28.1. Middle East Insulin Delivery Devices Market Overview
• 28.2. Middle East Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Insulin Delivery Devices Market

• 29.1. Africa Insulin Delivery Devices Market Overview
• 29.2. Africa Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Insulin Delivery Devices Market Competitive Landscape And Company Profiles

• 30.1. Insulin Delivery Devices Market Competitive Landscape
• 30.2. Insulin Delivery Devices Market Company Profiles
  • 30.2.1. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Insulin Delivery Devices Market Other Major And Innovative Companies

• 31.1. Novo Nordisk A/S
• 31.2. Becton, Dickinson and Company
• 31.3. EOFlow Co. Ltd.
• 31.4. Insulet Corporation
• 31.5. Tandem Diabetes Care Inc.
• 31.6. Ypsomed Holding AG
• 31.7. Xeris Pharmaceuticals Inc.
• 31.8. Beta Bionics Inc.
• 31.9. Zealand Pharma AS
• 31.10. Bigfoot Biomedical Inc.
• 31.11. Emperra GmbH
• 31.12. Animas Corporation
• 31.13. Debiotech SA
• 31.14. CeQur Corporation
• 31.15. Aerami Therapeutics Inc.

32. Global Insulin Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Insulin Delivery Devices Market

34. Recent Developments In The Insulin Delivery Devices Market

35. Insulin Delivery Devices Market High Potential Countries, Segments and Strategies

• 35.1 Insulin Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Insulin Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Insulin Delivery Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer